ArticleExploration of targeted anti-tumor therapy2026
Paclitaxel and carboplatin after disease progression on immune checkpoint inhibitor for patients with metastatic urothelial carcinoma.
Albert Jang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.